VHCP Management as of March 31, 2012
Portfolio Holdings for VHCP Management
VHCP Management holds 14 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 20.4 | $32M | 2.4M | 13.31 | |
| Medivation | 15.0 | $24M | 314k | 74.72 | |
| Neurocrine Biosciences (NBIX) | 13.7 | $21M | 2.7M | 7.97 | |
| Ardea Biosciences | 8.6 | $13M | 615k | 21.76 | |
| NPS Pharmaceuticals | 8.0 | $13M | 1.8M | 6.84 | |
| Anacor Pharmaceuticals In | 7.5 | $12M | 2.0M | 5.89 | |
| Ym Biosciences | 6.5 | $10M | 5.4M | 1.86 | |
| Chelsea Therapeutics International | 5.6 | $8.8M | 3.4M | 2.56 | |
| GTx | 5.2 | $8.2M | 2.1M | 3.85 | |
| ACADIA Pharmaceuticals (ACAD) | 4.6 | $7.2M | 3.4M | 2.15 | |
| Alexza Pharmaceuticals | 2.0 | $3.1M | 5.0M | 0.62 | |
| Threshold Pharmaceuticals | 1.3 | $2.0M | 225k | 8.80 | |
| Anthera Pharmaceuticals | 0.8 | $1.3M | 588k | 2.21 | |
| Array BioPharma | 0.8 | $1.2M | 354k | 3.41 |
